Try a single issue or save on a subscription Issues delivered straight to your door or device ...

There are many consequences of untreated OSA, and all of these are more likely with more-severe obstruction. Because people ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

Patients with Hidradenitis Suppurativa (HS) are at a significantly higher risk of obstructive sleep apnea (OSA) compared to ...

Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

The FDA approved the phase 2 Explore-OSA trial set to assess the highly selective aldosterone synthase inhibitor, ...

Obstructive sleep apnea (OSA) is associated with an increased risk for cardiovascular disease (CVD) in adults, even those younger than 40 years, according to a study published online June 6 in the ...

Pune, Jan. 21, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, The Sleep Apnea Devices market size was valued at USD 5.25 billion in 2023 and is expected to reach USD 9.43 billion by 2032, growing ...

A recent retrospective cohort study unveiled a crucial connection between obstructive sleep apnea (OSA) and an increased risk of developing and progressing age-related macular degeneration ...

Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...

Would you please address the dangers of untreated sleep apnea? Also, what do people do when they are unable to tolerate a CPAP (continuous positive airway pressure) machine?